Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: CIDP

Phase III trials in neurology – 2018 in review

January 24, 2019

Browse by Topic

MS (395)
AD (85)
PD (77)
COVID-19 (58)
BIOMARKERS IN MS (46)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)

EPILEPSY (34)
MIGRAINE (25)
SCHIZOPHRENIA (25)
STROKE (22)
Library (16)
ECTRIMS 2015 (12)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2021 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
AAN 2013 (9)
ECTRIMS 2018 (9)
ECTRIMS 2019 (9)
MS SEQUENCING (9)
AAN 2014 (9)
ECTRIMS 2013 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2021 (6)
ECTRIMS 2024 (6)
CHARCOT 2013 (6)
ECTRIMS 2017 (6)
AAN 2019 (6)
ECTRIMS 2022 (6)
ECTRIMS 2016 (5)
ANXIETY (5)
AAN 2024 (5)
AAN 2022 (5)
CCSVI (5)
BIPOLAR (5)
EAN 2015 (4)
NeuroSound (4)
BPD (4)
AAN 2023 (4)
EAN 2022 (3)
AAN 2020 (3)
EAN 2023 (3)
ENS 2013 (3)
AAN 2017 (3)
ECTRIMS-ACTRIMS 2023 (3)
EAN 2024 (3)
PAIN (3)
EAN 2020 (2)
SLEEP (2)
SPECIAL REPORT (2)
NEW DRUGS (2)
ACTRIMS Forum 2024 (2)
CMSC 2023 (2)
APA 2014 (2)
AAN 2018 (2)
TSC (1)
ACTRIMS 2023 (1)
hATTR (1)
ALS (1)
NEWS IN BRIEF (1)
ECTRIMS (1)
EAN (1)
SEIZURE (1)
APA 2016 (1)
AAN 2016 (1)
LUMBAR PUNCTURE (1)
AES 2024 (1)
GUIDELINES (1)
CONCUSSION (1)
EAN 2021 (1)
EAN 2019 (1)
INSOMNIA (1)
WEST NILE (1)
ACTRIMS 2022 (1)
LGS (1)
CIDP (1)
Dravet syndrome (1)
ADDICTION (1)
ECTRIMS 2020 (0)
EAN 2016 (0)
AAN (0)
BIOMARKERS (0)

View all Topics

Popular Posts

McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
New advances in epilepsy: highlights from AES 2024 posted on December 17, 2024
Proton pump inhibitors linked to neurological conditions posted on November 29, 2019

Copyright 2024 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions